Clinical and laboratory assays in the diagnosis of cutaneous adverse drug reactions

Israel Medical Association Journal

Volumn 6, Issue 1, 2004, Pages 50-51

  Goldberg, Ilan ^a   Gilburd, Boris ^b,c   Shovman, Ora ^b,c   Brenner, Sarah ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Allergy; Cutaneous adverse drug reactions; Erythema nodosum; Interferon gamma release test

Indexed keywords

ANALGESIC AGENT; ANTIRHEUMATIC AGENT; BETA GLUCURONIDASE; BROMIDE; ESTRADIOL; GAMMA INTERFERON; IODIDE; MINOCYCLINE; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; PENICILLIN G; PROGESTERONE; SALICYLIC ACID DERIVATIVE; SULFONAMIDE;

ANTIGEN ANTIBODY COMPLEX; ASSAY; DIAGNOSTIC TEST; DRUG DETOXIFICATION; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; EDITORIAL; ERYTHEMA NODOSUM; HUMAN; LYMPHOCYTE TRANSFORMATION TEST; MACROPHAGE MIGRATION INHIBITION; MAST CELL DEGRANULATION; PATHOGENESIS; PROVOCATION TEST; RADIOALLERGOSORBENT TEST; SENSITIVITY AND SPECIFICITY; SKIN MANIFESTATION; TH1 CELL; TOXICITY TESTING;

ANTIGEN-ANTIBODY COMPLEX; BASOPHIL DEGRANULATION TEST; BIAS (EPIDEMIOLOGY); CELL MIGRATION INHIBITION; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; FALSE NEGATIVE REACTIONS; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MAST CELLS; RADIOALLERGOSORBENT TEST; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOXICITY TESTS;

EID: 0346707286     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (13)

1. DeSwarte RD. Drug allergy - Problems and strategies. J Allergy Clin Immunol 1984;74:209-21.
2. Brenner S, Bialy-Golan A, Ruocco V. Drug-induced pemphigus. Clin Dermatol 1998;16:393-7.
3. Halevy S, Feuerman EJ. Drug induced eruptions which mimic skin diseases. Fam Physician 1984;12:267.
4. Wide L, Juhlin L. Detection of penicillin allergy of the immediate type by radioimmunoassay of reagins (IgE) to penicilloyl conjugates. Clin Allergy 1971;1:171.
5. Grunwald MH, Halevy S, Livni E. Allergic vasculitis induced by hydrochlorthiazide: Confirmation by mast cell degranulation test. Isr J Med Sci 1989;25:572-4.
6. Gimenez-Camarasa JM, Garcia-Calderon P, De Moragas JM. Lymphocyte transformation test in fixed drug eruption. N Engl J Med 1975;292:819-822
7. Sachs B, Ederman S, Al-Masaoudi T, Merk HF. In vitro drug allergy detection system incorporating human liver microsomes in chlorazepate-induced skin rash: Drug-specific proliferation associated with interleukin-5 secretion. Br J Dermatol 2001;144:316-20.
8. Watson B, Rhodes EL, Rosling AE. The release of beta glucuronidase from the white cells of patients with drug rashes when incubated in autologous plasma, with and without the addition of the causal drug. Br J Dermatol 1978;99:183-90.
9. Halevy S, Grunwald MH, Sandbank M, et al. Macrophage migration inhibition factor (MIF) as a diagnostic aid in drug eruptions. Harefuah 1991;121:147-9 (Hebrew).
10. Shoenfeld Y, Livni E, Shaklai M, Pinkhas J. Sensitization to ibuprofen in systemic lupus erythematosus. JAMA 1980;244:547-8.
11. Shoenfeld Y. "Leukopenia: Idiopathic or drug-induced" - How to differentiate? N Engl J Med 1982;307-251.
12. Halevy S, Cohen AD, Grossman N. In vitro interferon gamma release in diagnosis of cutaneous adverse drug reactions. Harefuah 2001;140:121-4 (Harefuah).
13. Halevy S, Gold I, Cohen AD, Grossman N. In vitro interferon-gamma release test in the diagnosis of drug-induced erythema nodosum. IMAJ 2004;6:60-61